"Thymineless" death in androgen-independent prostatic cancer cells

Biochem Biophys Res Commun. 1989 Nov 30;165(1):73-81. doi: 10.1016/0006-291x(89)91035-8.

Abstract

The molecular mechanism of "thymineless" death induced by 5-fluorodeoxyuridine or trifluorothymidine, in androgen-independent rat prostatic adenocarcinoma AT-3 cells was investigated. Fragmentation of genomic DNA into discrete multiples of a nucleosomal unit (i.e. 180bp subunit) and induction of expression of TRPM-2, a programmed cell death-associated gene, temporally correlated with the activation of programmed cell death in this system. In contrast, killing of AT-3 cells by osmotic lysis, or membrane-targeted metabolic inhibitors results in neither the stereotypic DNA fragmentation into nucleosomal oligomers nor the elevation of TRPM-2 mRNA levels but to non-specific biochemical changes characteristic of necrosis. These results suggest that androgen-independent prostatic cancer cells retain a major portion of the programmed cell death cascade which can be activated by non-androgen ablative cytotoxic drugs that induce "thymineless" death.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Blotting, Northern
  • Cell Line
  • Cell Survival / drug effects*
  • DNA, Neoplasm / analysis
  • DNA, Neoplasm / drug effects
  • DNA, Neoplasm / genetics
  • Drug Screening Assays, Antitumor
  • Floxuridine / pharmacology*
  • Iodoacetates / pharmacology
  • Iodoacetic Acid
  • Male
  • Nucleic Acid Hybridization
  • Ouabain / pharmacology
  • Prostatic Neoplasms / metabolism
  • Prostatic Neoplasms / pathology*
  • Rats
  • Thymidine
  • Thymine / metabolism*
  • Trifluridine / pharmacology*

Substances

  • DNA, Neoplasm
  • Iodoacetates
  • Floxuridine
  • Ouabain
  • Thymine
  • Trifluridine
  • Thymidine
  • Iodoacetic Acid